Cargando…

Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies

Promptly after primoinfection, HIV generates a pool of infected cells carrying transcriptionally silent integrated proviral DNA, the HIV-1 reservoir. These cells are not cleared by combined antiretroviral therapy (cART), and persist lifelong in treated HIV-infected individuals. Defining clinical str...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrillo, Jorge, Clotet, Bonaventura, Blanco, Julià
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205993/ https://www.ncbi.nlm.nih.gov/pubmed/30405624 http://dx.doi.org/10.3389/fimmu.2018.02429

Ejemplares similares

Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target
por: Molinos-Albert, Luis M., et al.
Publicado: (2017)

Expansion of antibody secreting cells and modulation of neutralizing antibody activity in HIV infected individuals undergoing structured treatment interruptions
por: Llano, Anuska, et al.
Publicado: (2013)

Syphilis vaccine: challenges, controversies and opportunities
por: Ávila-Nieto, Carlos, et al.
Publicado: (2023)

Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals
por: Molinos-Albert, Luis M, et al.
Publicado: (2014)

Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity
por: Carrillo, Jorge, et al.
Publicado: (2021)

Gp120/CD4 Blocking Antibodies Are Frequently Elicited in ART-Naïve Chronically HIV-1 Infected Individuals
por: Carrillo, Jorge, et al.
Publicado: (2015)

Broadly Neutralizing Antibodies for HIV Eradication
por: Stephenson, Kathryn E., et al.
Publicado: (2016)

Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function
por: Curriu, Marta, et al.
Publicado: (2012)

Low levels of anti-MPER antibodies are detectable in viremic HIV infected
por: Carrillo, J, et al.
Publicado: (2012)

T-Follicular-Like CD8(+) T Cell Responses in Chronic HIV Infection Are Associated With Virus Control and Antibody Isotype Switching to IgG
por: Romero-Martín, Luis, et al.
Publicado: (2022)

Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
por: Bernard, Nicole F., et al.
Publicado: (2022)

New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness
por: Corraliza-Gorjón, Isabel, et al.
Publicado: (2017)

The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies
por: Baysal, Hasan, et al.
Publicado: (2021)

Eradication of HIV and Cure of AIDS, Now and How?
por: Zhang, Jielin, et al.
Publicado: (2013)

TLR-Agonist Mediated Enhancement of Antibody-Dependent Effector Functions as Strategy For an HIV-1 Cure
por: Hvilsom, Caroline Thue, et al.
Publicado: (2021)

Strategies for Generating Diverse Antibody Repertoires Using Transgenic Animals Expressing Human Antibodies
por: Chen, Weihsu C., et al.
Publicado: (2018)

Antibody-Based Strategies to Prevent and Treat Influenza
por: Shriver, Zachary, et al.
Publicado: (2015)

Which Antibody Functions are Important for an HIV Vaccine?
por: Su, Bin, et al.
Publicado: (2014)

Neutralization-Enhancing RF Antibodies for HIV Vaccines
por: Suslov, Konstantin V.
Publicado: (2014)

Broadly Neutralizing Antibodies for HIV-1 Prevention
por: Walsh, Stephen R., et al.
Publicado: (2021)

Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
por: Lee, Wen Shi, et al.
Publicado: (2021)

Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy
por: Toscani, Denise, et al.
Publicado: (2018)

Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-Seroconvertors
por: Kilpeläinen, Athina, et al.
Publicado: (2022)

A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors
por: Davis-Gardner, Meredith E., et al.
Publicado: (2023)

A Generic Strategy to Generate Bifunctional Two-in-One Antibodies by Chicken Immunization
por: Harwardt, Julia, et al.
Publicado: (2022)

Development of antibody-dependent cell cytotoxicity function in HIV-1 antibodies
por: Doepker, Laura E, et al.
Publicado: (2021)

Autoreactivity and broad neutralization of antibodies against HIV-1 are governed by distinct mutations: Implications for vaccine design strategies
por: Li, Xiaojun, et al.
Publicado: (2022)

Lovastatin Inhibits HIV-1-Induced MHC-I Downregulation by Targeting Nef–AP-1 Complex Formation: A New Strategy to Boost Immune Eradication of HIV-1 Infected Cells
por: Liu, Bingfeng, et al.
Publicado: (2019)

Increasing the Clinical Potential and Applications of Anti-HIV Antibodies
por: Hua, Casey K., et al.
Publicado: (2017)

Non-Neutralizing Antibodies Directed against HIV and Their Functions
por: Mayr, Luzia M., et al.
Publicado: (2017)

On the steps of cell-to-cell HIV transmission between CD4 T cells
por: Puigdomènech, Isabel, et al.
Publicado: (2009)

Molecular Insights of Nickel Binding to Therapeutic Antibodies as a Possible New Antibody Superantigen
por: Su, Chinh Tran-To, et al.
Publicado: (2021)

Identification of a HIV Gp41-Specific Human Monoclonal Antibody With Potent Antibody-Dependent Cellular Cytotoxicity
por: Yang, Zheng, et al.
Publicado: (2018)

Editorial: HIV-Induced Damage of B Cells and Production of HIV Neutralizing Antibodies
por: Chiodi, Francesca, et al.
Publicado: (2018)

HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression
por: Kammers, Kai, et al.
Publicado: (2021)

Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?
por: Chan, Chilam, et al.
Publicado: (2022)

The Effects of Framework Mutations at the Variable Domain Interface on Antibody Affinity Maturation in an HIV-1 Broadly Neutralizing Antibody Lineage
por: Zhou, Jeffrey O., et al.
Publicado: (2020)

Contribution to HIV Prevention and Treatment by Antibody-Mediated Effector Function and Advances in Broadly Neutralizing Antibody Delivery by Vectored Immunoprophylaxis
por: Phelps, Meredith, et al.
Publicado: (2021)

Dramatic Potentiation of the Antiviral Activity of HIV Antibodies by Cholesterol Conjugation
por: Lacek, Krzysztof, et al.
Publicado: (2014)

Neutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success
por: Jaworski, Juan Pablo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g589dnp1i6gbhetksffr7opugl